18. Lo E. H., Hara H., Rogowska J., Trocha M., Pierce A. R., Huang P. L., Fishman M. C., Wolf G. L. and Moskowitz
M. A. (1996) Temporal correlation mapping analysis of the hemodynamic penumbra in mutant mice deficient in
endothelial nitric oxide synthase gene expression. Stroke 27, 1381–1386.
19. Lo E. H., Pierce A. R., Matsumoto K., Kano T., Evans C. J. and Newcomb R. (1998) Alterations in K+ evoked
profiles of neurotransmitter and neuromodulator amino acids after focal ischemia-reperfusion. Neuroscience 83,
449–458.
20. Luo D. and Vincent S. R. (1994) NMDA dependent nitric oxide release in the hippocampus in vivo: interactions with
noradrenaline. Neuropharmacology 33, 1345–1350.
21. Mayer B., Klatt P., Werner E. R. and Schimdt K. (1994) Molecular mechanisms of inhibition of porcine brain nitric
oxide synthase by the antinociceptive drug 7-nitro-indazole. Neuropharmacology 33, 1253–1259.
22. MeVert M. K., Premarck B. and Schulman H. (1994) Nitric oxide stimulates Ca-independent synaptic vesicle release.
Neuron 12, 1235–1244.
23. Montague P. R., Gancayco C. D., Winn M. J., Marchase R. B. and Friedlander M. J. (1994) Role of NO production
in NMDA receptor mediated neurotransmitter release in cerebral cortex. Science 263, 973–977.
24. Nicholls D. and Attwell D. (1990) The release and uptake of excitatory amino acids. Trends Pharmac. Sci. 11,
462–478.
25. Nicholls D. G. (1989) Release of glutamate, aspartate and GABA from isolated nerve terminals. J. Neurochem. 52,
331–337.
26. O'Dell T. J., Hawkins R. D., Kandel E. R. and Arancio O. (1991) Tests of the roles of two diVusible substances in long
term potentiation: evidence for NO as a possible early retrograde messenger. Proc. natn. Acad. Sci. U.S.A. 88,
11,285–11,289.
27. O'Dell T. J., Huang P. L., Dawson T. M., Dinerman J. L., Snyder S. H., Kandel E. R. and Fishman M. C. (1994)
Endothelial NOS and the blockade of LTP by NOS inhibitors in mice lacking neuronal NOS. Science 265, 542–546.
28. Schulz J. B., Matthews R. T., Jenkins B. G., Ferrante R. J., Siwek D., Henshaw R., Kowall N. W., Rosen B. R. and
Beal M. F. (1995) Blockade of neuronal nitric oxide synthase protects against excitotoxicity in vivo. J. Neurosci. 15,
8419–8429.
29. Schuman E. M. and Madison D. V. (1994) Locally distributed synaptic potentiation in the hippocampus. Science 263,
532–536.
30. Selicovich A., Duvilanski B. H., Pisera D., Theas S., Gimeno M., Retorri V., McCann S. M. (1995) Nitric oxide
inhibits hypothalamic lutenizing hormne releasing hormone release by releasing GABA. Proc. natn. Acad. Sci. U.S.A.
92, 3421–3424.
31. Silva M. T., Rose S., Hindmarsh J. G., Aislaitner G., Gorrod J. W., Moore P. K., Jenner P. and Marsden C. D. (1995)
Increased strital dopamine eZux in vivo following inhibition of cerebral nitric oxide synthase by the novel
monosodium salt of 7-nitro-indazole. Br. J. Pharmac. 114, 257–258.
32. Son H., Hawkins R. D., Martin K., Kiebler M., Huang P. L., Fishman M. C. and Kandel E. R. (1997) Long term
potentiation is reduced in mice that are doubly mutant in endothelial and neuronal NO synthase. Cell 87,
1015–1023.
33. Wieraszko A., Li G., Korncki E., Hogan M. V. and Ehrlich Y. H. (1993) Long term potentiation in the hippocampus
induced by platelet activating factor. Neuron 16, 553–557.
34. Williams J. H., Errington M. L., Lynch M. A. and Bliss T. V. P. (1989) Arachadonic acid induces long term activity
dependent enhancement of synaptic enhancement in the hippocampus. Nature 341, 739–742.
35. Wood J. and Garthwaite J. (1994) Models of the diVusional spread of nitric oxide: implications for neural nitric oxide
signaling and its pharmacological properties. Neuropharmacology 33, 1235–1244.
36. Zhuo M., Small S. A., Kandel E. R. and Hawkins R. D. (1993) Nitric oxide and carbon monoxide produce
activity-dependent long term synaptic enhancement in hippocampus. Science 260, 1946–1950.
